Advances in human placenta-derived stem cells for liver regeneration
10.3760/cma.j.issn.1007-8118.2013.03.020
- VernacularTitle:胎盘源性干细胞在肝脏疾病中的研究进展
- Author:
Jian WANG
;
Zhengyan ZHU
;
Zhi DU
- Publication Type:Journal Article
- Keywords:
Human placenta-derived stem cells (hPDSCs);
Human placenta mesenchymal stem cells (hPMSCs);
Hepatocyte;
Regeneration;
Apoptosis
- From:
Chinese Journal of Hepatobiliary Surgery
2013;(3):236-240
- CountryChina
- Language:Chinese
-
Abstract:
Human placenta-derived stem cells (hPD-SCs) are a mixed group of stem cells.Stem cell medicine has applications for organ damage or failure through regenerative,anti-apoptotic,anti-inflammatory and anti-tumor properties in addition to cell function recovery.Presently,human placenta mesenchymal stem cells (hPMSCs) have similar characteristics to the differentiation of hepatocyte-like cells by promoting hepatocyte regeneration,anti-hepatocyte apoptosis and anti-liver fibrosis,in vitro or in animal models.To further our investigation,a summary of the origin,sorting and biological properties of hPDSCs along with a narration of hPDSCs for liver disease therapy was written.This leads to a discussion for new ideas to further explore cell treatment for liver disease.